Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression

Published:2023-10 Issue: Volume:169 Page:477-488
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Wu Danjun,Zhao Zejing,Liu Hong,Fu Kaili,Ji Yaning,Ji Weili,Li Yazhen,Yan Qinying,Yang Gensheng

Funder

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference37 articles.

1. Deep tumor penetration of drug-loaded nanoparticles by click reaction-assisted immune cell targeting strategy;Lee;J. Am. Chem. Soc.,2019

2. Obstacles and opportunities in a forward vision for cancer nanomedicine;de Lázaro;Nat. Mater.,2021

3. Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia;Sahu;Biomaterials,2020

4. Bioengineered and biohybrid bacteria-based systems for drug delivery;Hosseinidoust;Adv. Drug Deliv. Rev.,2016

5. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy;Chen;Biomaterials,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of bacteria-nanomaterial hybrids in antitumor therapy;Journal of Nanobiotechnology;2024-09-04

2. Research Progress on the Mechanism, Monitoring, and Prevention of Cardiac Injury Caused by Antineoplastic Drugs—Anthracyclines;Biology;2024-09-03

3. Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives;Life Sciences;2024-09

4. Light-Driven Microrobots for Targeted Drug Delivery;ACS Biomaterials Science & Engineering;2024-08-15

5. Chitosan nanomedicines-engineered bifidobacteria complexes for effective colorectal tumor-targeted delivery of SN-38;International Journal of Pharmaceutics;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3